Digital platforms designed to simplify complexity across biopharma and healthcare.
We are building a portfolio of digital platforms designed to simplify complexity, combining AI, data, and user-centered design to enable better decisions, faster workflows, and improved outcomes.
BioXion
AI-powered development intelligence platform for biopharmaceutical companies and CDMOs.
Covers CMC, Quality, Partner Programs, Analytical, Regulatory, and Supply Chain, connecting workflows and enabling smarter decisions across the development lifecycle.
By centralising data and workflows, BioXion helps teams reduce coordination gaps, improve decision-making, and accelerate development timelines with greater confidence.
FormulytiX
AI-powered formulation intelligence for biologics, vaccines and complex molecules.
FormulytiX is a focused decision-support platform designed to transform how formulation strategies are developed — combining RAG-based knowledge retrieval, in silico stability modeling, and structured scientific reasoning.
Designed to complement platforms like BioXion and future-integrate with upstream discovery systems, FormulytiX bridges the gap between molecular insight and formulation strategy.
IVF Companion
IVF Companion is a patient-centered digital platform designed to guide individuals through complex fertility treatments. It provides structured information, tracking tools, and personalised support throughout the IVF journey.
The platform bridges the gap between clinic visits by offering continuous guidance, helping patients stay informed, organised, and supported, while also reducing administrative burden for care teams.
Building the Future of Biopharma and Healthcare Platforms
Together, our products combine deep domain expertise with modern technology to address real-world challenges across the healthcare ecosystem, from drug development to patient care. We enable organizations to streamline complex workflows, improve decision-making through data and AI, and deliver better outcomes at every stage of the lifecycle.
